Very recently, Xie et al. investigated the effects of intraperitoneal injection of adiponectin in mice with chronic TNBS-induced colitis and they observed that adiponectin treatment reduced inflammatory markers such as colon myeloperoxidase activity and pro-inflammatory cytokines [25]. This evidence concerns the gene ADIPOQ and colitis.